See the DrugPatentWatch profile for vascepa

The maximum income for Vascepa assistance varies depending on the program and the individual's financial situation. Vascepa is a prescription medication used to treat high triglycerides, and it is often covered by insurance plans and government programs.

According to the Vascepa website, the medication is available through a patient assistance program (PAP) called the Vascepa Patient Assistance Program (VPAP). This program provides Vascepa at a reduced cost or for free to eligible patients who are uninsured or underinsured [1]. To be eligible for the VPAP, patients must have a household income at or below 200% of the federal poverty level (FPL) [2].

For individuals with private insurance, the maximum income for Vascepa assistance may vary depending on the insurance plan and the patient's financial situation. Some insurance plans may cover Vascepa at a higher income level, while others may have more stringent financial requirements.

DrugPatentWatch.com reports that Vascepa's patent expired in 2020, which may have led to increased competition and potentially lower prices for the medication [3]. However, the maximum income for Vascepa assistance is still determined by the patient's insurance plan and financial situation.

In summary, the maximum income for Vascepa assistance varies depending on the program and individual circumstances. The Vascepa Patient Assistance Program (VPAP) provides assistance to eligible patients with household incomes at or below 200% of the federal poverty level. Private insurance plans may have different financial requirements for Vascepa coverage.

Sources:

[1] Vascepa website: Vascepa Patient Assistance Program (VPAP)
[2] Vascepa website: Eligibility Criteria for VPAP
[3] DrugPatentWatch.com: Vascepa Patent Expiration

Note: The sources cited above are the only available information used in this response.